Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HEXA | P06865 | 1/20 | 0.31 |
| ▸ | HEXB | P07686 | 1/20 | 0.31 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL115148 | 0.87 | MEN1 (0.40) | LMNASMN1; SMN2MEN1TSHRALOX12 | |
| SCHEMBL115300 | 0.87 | ADORA3 (0.34) | ADORA3LMNASMN1; SMN2RAB9ACASR | |
| SCHEMBL115325 | 0.84 | HEXA (0.36) | ADORA3LMNASMN1; SMN2RAB9AHEXA | |
| SCHEMBL113824 | 0.84 | ADORA3 (0.32) | ADORA3LMNASMN1; SMN2RAB9ACASR | |
| SCHEMBL113840 | 0.84 | ADORA3 (0.33) | ADORA3LMNASMN1; SMN2RAB9ACASR | |
| SCHEMBL115975 | 0.84 | CASR (0.34) | LMNAMEN1TSHRALOX12MAPK1 | |
| SCHEMBL114953 | 0.84 | METAP2 (0.38) | LMNAMEN1TSHRALOX12MAPK1 | |
| SCHEMBL115332 | 0.83 | TLR8 (0.35) | ADORA3LMNASMN1; SMN2RAB9AHEXA | |
| SCHEMBL113713 | 0.83 | KDM4E (0.36) | SMN1; SMN2RAB9AMEN1KMT2ANPSR1 | |
| SCHEMBL113825 | 0.82 | MAPT (0.33) | ADORA3LMNASMN1; SMN2RAB9ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058893-A1 | HERBICIDALLY ACTIVE KETOSULTAMS AND DIKETOPYRIDINES | BAYER CROPSCIENCE AG (DE) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058893-A1 | HERBICIDALLY ACTIVE KETOSULTAMS AND DIKETOPYRIDINES | KHK, KCNA1, KCNA2 | ADORA3 1900/4885LMNA 3651/4885SMN1; SMN2 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.